Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Antivirals
Investigators at United States Army Medical Research Institute of Infectious Disease publish new data on antivirals
May 21st, 2008
Current study results from the report, 'Oligonucleotide antiviral therapeutics: antisense and RNA interference for highly pathogenic RNA viruses,' have been published. According to recent research published in the journal Antiviral Research, "RNA viruses are a significant source of morbidity and mortality in humans every year. Additionally, the potential use of these viruses in acts of bioterrorism poses a threat to national security." "Given the paucity of vaccines or postexposure therapeutics for many highly pathogenic RNA viruses, novel treatments are badly needed. Sequence-based drug design, under development for almost 20 years, is proving effective in...
Source: Vaccine Weekly (2008-05-21)
|